Title : Heparin-binding EGF-like growth factor is a promising target for ovarian cancer therapy.

Pub. Date : 2004 Aug 15

PMID : 15313912






3 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 LPA, which is constitutively produced by ovarian cancer cells, induced HB-EGF ectodomain shedding in SKOV3 and RMG-1 cells, resulting in the transactivation of EGFR and the downstream kinase extracellular signal-regulated kinase/mitogen-activated protein kinase. lysophosphatidic acid epidermal growth factor receptor Homo sapiens
2 Introduction of lipid phosphate phosphohydrolase, which hydrolyzes LPA, decreased the constitutive shedding of HB-EGF, EGFR transactivation, and the tumorigenic potential of SKOV3 and RMG-1 cells. lysophosphatidic acid epidermal growth factor receptor Homo sapiens
3 These results indicate that HB-EGF is the primary member of the EGFR family of growth factors expressed in ovarian cancer and that LPA-induced ectodomain shedding of this growth factor is a critical step in tumor formation, making HB-EGF a novel therapeutic target for ovarian cancer. lysophosphatidic acid epidermal growth factor receptor Homo sapiens